Rutgers Cancer Institute section chief receives distinguished service award

Richard Drachtman
Richard Drachtman

Richard Drachtman, MD, received the Distinguished Service Award from Melvyn H. Motolinsky Research Foundation, established to support research into leukemia and other blood-related diseases.

The award recognizes accomplishments and leadership in the field of pediatric cancer and blood disorders.

Drachtman is clinical section chief of the pediatric hematology/oncology division at Rutgers Cancer Institute of New Jersey. He also is professor of pediatrics at Rutgers Robert Wood Johnson Medical School and director of the Rutgers Robert Wood Johnson Medical School Regional Comprehensive Sickle Cell Center.

“I am humbled to be the recipient of this year’s Distinguished Service Award from the Melvyn H. Motolinsky Research Foundation,” Drachtman said in a press release. “While an individual honor, there are numerous others — including my colleagues at Rutgers Cancer Institute — who impact our center’s research and treatment efforts so that we can deliver the best care to our patients.”

Drachtman is recognized for his research into and expertise in childhood cancer — including Hodgkin lymphoma — and sickle cell disease.

“As New Jersey Jersey’s only NCI-designated comprehensive cancer center, Rutgers Cancer Institute has an obligation to conduct in-depth research and translate that science into cutting-edge treatments. Dr. Drachtman’s expertise in this area is unsurpassed,” Peter D. Cole, MD, chief of pediatric hematology/oncology at Rutgers Cancer Institute, said in the release. “As a result of his leadership both locally and nationally, we have the opportunity to continually improve outcomes for our pediatric and young adult patients.”

Richard Drachtman
Richard Drachtman

Richard Drachtman, MD, received the Distinguished Service Award from Melvyn H. Motolinsky Research Foundation, established to support research into leukemia and other blood-related diseases.

The award recognizes accomplishments and leadership in the field of pediatric cancer and blood disorders.

Drachtman is clinical section chief of the pediatric hematology/oncology division at Rutgers Cancer Institute of New Jersey. He also is professor of pediatrics at Rutgers Robert Wood Johnson Medical School and director of the Rutgers Robert Wood Johnson Medical School Regional Comprehensive Sickle Cell Center.

“I am humbled to be the recipient of this year’s Distinguished Service Award from the Melvyn H. Motolinsky Research Foundation,” Drachtman said in a press release. “While an individual honor, there are numerous others — including my colleagues at Rutgers Cancer Institute — who impact our center’s research and treatment efforts so that we can deliver the best care to our patients.”

Drachtman is recognized for his research into and expertise in childhood cancer — including Hodgkin lymphoma — and sickle cell disease.

“As New Jersey Jersey’s only NCI-designated comprehensive cancer center, Rutgers Cancer Institute has an obligation to conduct in-depth research and translate that science into cutting-edge treatments. Dr. Drachtman’s expertise in this area is unsurpassed,” Peter D. Cole, MD, chief of pediatric hematology/oncology at Rutgers Cancer Institute, said in the release. “As a result of his leadership both locally and nationally, we have the opportunity to continually improve outcomes for our pediatric and young adult patients.”